Hikma Pharmaceuticals (HIK)

 

Latest News

Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC

Citigroup today reaffirms its neutral investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and set its price target...

Broker Forecast - Goldman Sachs issues a broker note on Hikma Pharmaceuticals PLC

Goldman Sachs today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to neutral (from buy...

Stockwatch: Is this a coiled spring or a falling knife?

It's likely private investors are eyeing this mid cap up but sitting on their hands for now. This could be of interest to vigilan...

Peel Hunt cuts earnings by 30% for Hikma

Peel Hunt has cut its earnings by 30% for Hikma Pharma (LON:HIK), while the price target falls to 13.90 from 21.50. The do...

All News

DateHeadlineSource
24-08-17Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
22-08-17Broker Forecast - Goldman Sachs issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
22-08-17Stockwatch: Is this a coiled spring or a falling knife?Interactive Investor
21-08-17Peel Hunt cuts earnings by 30% for HikmaStockMarketWire
21-08-17Broker Forecast - Morgan Stanley issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
21-08-17Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
21-08-17Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
17-08-17FTSE remains weak on underwhelming financial stocks StockMarketWire
17-08-17Down 50% since March but still a 'buy'Interactive Investor
17-08-17Slump in banking stocks hit FTSE StockMarketWire
17-08-17FTSE weaker as pound strengthensStockMarketWire
17-08-17Hikma core operating profits upStockMarketWire
17-08-17Hikma announces licensing agreement with TakedaRNS
17-08-17Half-year ReportRNS
11-08-17Broker Forecast - Numis issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
10-08-17Director/PDMR ShareholdingRNS
10-08-17Director/PDMR ShareholdingRNS
09-08-17Director/PDMR ShareholdingRNS
04-08-17Holding(s) in CompanyRNS
03-08-17Hikma schedules interim results announcementStockMarketWire
03-08-17Notice of ResultsRNS
02-08-17Broker views: Pharma and supermarketsStockMarketWire
02-08-17Broker Forecast - Morgan Stanley issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
24-07-17Holding(s) in CompanyRNS
04-07-17Total Voting RightsRNS
03-07-17Holding(s) in CompanyRNS
30-06-17Holding(s) in CompanyRNS
27-06-17Broker Forecast - HSBC issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
26-06-17Hikma's US CEO to retire StockMarketWire
26-06-17Leadership and Structural Changes to US BusinessRNS
16-06-17The week ahead: Big day for Sirius MineralsInteractive Investor
12-06-17Director/PDMR ShareholdingRNS
02-06-17Total Voting RightsRNS
31-05-17Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
31-05-17Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
31-05-17Director/PDMR ShareholdingRNS
23-05-17Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
23-05-17Broker Forecast - Cantor Fitzgerald issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
22-05-17Broker Forecast - Numis issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
19-05-17Miners rally on stronger commodity pricesStockMarketWire

RSS feeds

  • Editorial news feed for LSE:HIK Editorial
  • Regulatory news feed for LSE:HIK Regulatory